GB0108337D0 - Organic compounds - Google Patents
Organic compoundsInfo
- Publication number
- GB0108337D0 GB0108337D0 GBGB0108337.7A GB0108337A GB0108337D0 GB 0108337 D0 GB0108337 D0 GB 0108337D0 GB 0108337 A GB0108337 A GB 0108337A GB 0108337 D0 GB0108337 D0 GB 0108337D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- organic compounds
- compounds
- organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000002894 organic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (27)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0108337.7A GB0108337D0 (en) | 2001-04-03 | 2001-04-03 | Organic compounds |
| ARP020101141A AR035451A1 (es) | 2001-04-03 | 2002-03-27 | Derivados de beta-carbolina, su uso para la fabricacion de un medicamento para el tratamiento de la depresion, ansiedad y desordenes bipolares, una composicion farmaceutica y una combinacion. |
| CZ20032655A CZ295992B6 (cs) | 2001-04-03 | 2002-04-02 | Beta-karbolinové deriváty, způsob jejich přípravy a farmaceutické prostředky s jejich obsahem |
| MYPI20021189A MY134026A (en) | 2001-04-03 | 2002-04-02 | ?-carboline derivatives and its pharmaceutical use against depression and anxiety |
| AU2002316828A AU2002316828B2 (en) | 2001-04-03 | 2002-04-02 | Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| RU2003130644/04A RU2003130644A (ru) | 2001-04-03 | 2002-04-02 | Производные ркарболина и их фармацевтическое применение против дипрессии и страха |
| MXPA03009057A MXPA03009057A (es) | 2001-04-03 | 2002-04-02 | Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad. |
| US10/472,630 US6861430B2 (en) | 2001-04-03 | 2002-04-02 | β-carboline derivatives and its pharmaceutical use against depression and anxiety |
| EP02745204A EP1377578B1 (en) | 2001-04-03 | 2002-04-02 | Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| IL15754502A IL157545A0 (en) | 2001-04-03 | 2002-04-02 | Beta-carboline derivatives and their pharmaceutical use against depression and anxiety |
| HU0400317A HUP0400317A3 (en) | 2001-04-03 | 2002-04-02 | Beta-carboline derivatives, process for their preparation, their use and pharmaceutical compositions containing them |
| KR1020037012933A KR100564840B1 (ko) | 2001-04-03 | 2002-04-02 | 베타-카르볼린 유도체 및 우울증 및 불안증에 있어서 그의제약상 용도 |
| JP2002579459A JP4405732B2 (ja) | 2001-04-03 | 2002-04-02 | β−カルボリン誘導体ならびにうつ病および不安に対する医薬的使用 |
| PT02745204T PT1377578E (pt) | 2001-04-03 | 2002-04-02 | Derivados de beta-carbolina e o seu uso farmacêutico contra a depressão e ansiedade |
| NZ528370A NZ528370A (en) | 2001-04-03 | 2002-04-02 | Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| AT02745204T ATE517104T1 (de) | 2001-04-03 | 2002-04-02 | Beta-carbolinderivate und deren pharmazeutische verwendung gegen depression und angst |
| PE2002000264A PE20021018A1 (es) | 2001-04-03 | 2002-04-02 | DERIVADOS DE ß - CARBOLINA |
| CNB028077814A CN1309721C (zh) | 2001-04-03 | 2002-04-02 | β－咔啉衍生物及其抗抑郁和抗焦虑的药物应用 |
| ES02745204T ES2368389T3 (es) | 2001-04-03 | 2002-04-02 | Derivados de beta-carbolina y uso farmacéutico contra la depresión y la ansiedad. |
| PCT/EP2002/003624 WO2002081471A1 (en) | 2001-04-03 | 2002-04-02 | Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| CA2440014A CA2440014C (en) | 2001-04-03 | 2002-04-02 | Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| SK1222-2003A SK12222003A3 (sk) | 2001-04-03 | 2002-04-02 | Beta-karbolínové deriváty, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitia proti depresii a úzkosti |
| PL362571A PL210861B1 (pl) | 2001-04-03 | 2002-04-02 | Pochodna beta-karboliny,kompozycja farmaceutyczna zawierająca pochodną beta-karboliny oraz zastosowanie pochodnej beta-karboliny |
| BRPI0208566-6B1A BR0208566B1 (pt) | 2001-04-03 | 2002-04-02 | Derivados de Beta-Carbolina, Seu Uso, e composição Farmacêutica |
| ZA200306108A ZA200306108B (en) | 2001-04-03 | 2003-08-07 | Beta-carboline derivatives and its pharmaceutical use against depression and anxiety. |
| EC2003004754A ECSP034754A (es) | 2001-04-03 | 2003-08-27 | Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad |
| NO20034413A NO20034413L (no) | 2001-04-03 | 2003-10-02 | Beta-karbolinderivater og deres farmasöytiske anvendelse mot depresjon og angst |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0108337.7A GB0108337D0 (en) | 2001-04-03 | 2001-04-03 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0108337D0 true GB0108337D0 (en) | 2001-05-23 |
Family
ID=9912165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0108337.7A Ceased GB0108337D0 (en) | 2001-04-03 | 2001-04-03 | Organic compounds |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6861430B2 (enExample) |
| EP (1) | EP1377578B1 (enExample) |
| JP (1) | JP4405732B2 (enExample) |
| KR (1) | KR100564840B1 (enExample) |
| CN (1) | CN1309721C (enExample) |
| AR (1) | AR035451A1 (enExample) |
| AT (1) | ATE517104T1 (enExample) |
| AU (1) | AU2002316828B2 (enExample) |
| BR (1) | BR0208566B1 (enExample) |
| CA (1) | CA2440014C (enExample) |
| CZ (1) | CZ295992B6 (enExample) |
| EC (1) | ECSP034754A (enExample) |
| ES (1) | ES2368389T3 (enExample) |
| GB (1) | GB0108337D0 (enExample) |
| HU (1) | HUP0400317A3 (enExample) |
| IL (1) | IL157545A0 (enExample) |
| MX (1) | MXPA03009057A (enExample) |
| MY (1) | MY134026A (enExample) |
| NO (1) | NO20034413L (enExample) |
| NZ (1) | NZ528370A (enExample) |
| PE (1) | PE20021018A1 (enExample) |
| PL (1) | PL210861B1 (enExample) |
| PT (1) | PT1377578E (enExample) |
| RU (1) | RU2003130644A (enExample) |
| SK (1) | SK12222003A3 (enExample) |
| WO (1) | WO2002081471A1 (enExample) |
| ZA (1) | ZA200306108B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| JP4671123B2 (ja) * | 2003-06-23 | 2011-04-13 | 小野薬品工業株式会社 | 新規三環性複素環化合物 |
| AR051780A1 (es) * | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos |
| DK1829874T3 (da) * | 2004-12-22 | 2014-05-12 | Ono Pharmaceutical Co | Tricyklisk forbindelse og anvendelse deraf |
| US7879859B2 (en) | 2005-11-21 | 2011-02-01 | Merck Sharp & Dohme Corp. | Diagnosis and treatment of type 2 diabetes and other disorders |
| US20070149557A1 (en) * | 2005-11-21 | 2007-06-28 | Amgen Inc. | CXCR3 antagonists |
| AU2008276568A1 (en) * | 2007-07-19 | 2009-01-22 | Merck & Co., Inc. | Beta carboline derivatives as antidiabetic compounds |
| WO2009016329A1 (en) * | 2007-07-31 | 2009-02-05 | Cambridge Enterprise Limited | Use of gabaa receptor antagonists to treat cognitive impairment in patients with psychiatric conditions |
| EP2300466B1 (en) | 2008-06-20 | 2014-08-06 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors |
| ES2541528T3 (es) | 2008-11-19 | 2015-07-21 | Forum Pharmaceuticals Inc. | Tratamiento de trastornos cognitivos con (R)-7-cloro-N-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma |
| TW201028414A (en) * | 2009-01-16 | 2010-08-01 | Merck Sharp & Dohme | Oxadiazole beta carboline derivatives as antidiabetic compounds |
| CN102695414A (zh) | 2010-01-15 | 2012-09-26 | 默沙东公司 | 作为抗糖尿病化合物的噁二唑β-咔啉衍生物 |
| JP5749797B2 (ja) | 2010-05-17 | 2015-07-15 | フォルム ファーマシューティカルズ、インコーポレイテッド | （ｒ）−７−クロロ−ｎ−（キヌクリジン−３−イル）ベンゾ［ｂ］チオフェン−２−カルボキサミド塩酸塩一水和物の結晶形 |
| CA2872005A1 (en) | 2012-05-08 | 2013-11-14 | Forum Pharmaceuticals, Inc. | Methods of maintaining, treating or improving cognitive function |
| CN111349096B (zh) * | 2020-04-14 | 2021-03-09 | 石河子大学 | 一种吲哚类化合物及其制备方法、应用 |
| KR102467844B1 (ko) | 2021-04-21 | 2022-11-16 | 삼성전자주식회사 | 솔리드 스테이트 드라이브 장치 및 이를 포함하는 데이터 저장 장치 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4118741A1 (de) * | 1991-06-05 | 1992-12-10 | Schering Ag | Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln |
| US6057340A (en) * | 1998-02-03 | 2000-05-02 | American Home Products Corporation | Oxazole derivatives as serotonin-1A receptor agonists |
| NZ508765A (en) * | 1998-06-12 | 2003-10-31 | Sod Conseils Rech Applic | Beta-carboline derivatives and pharmaceuticals thereof that selectively bind somatostatin receptor subtypes |
-
2001
- 2001-04-03 GB GBGB0108337.7A patent/GB0108337D0/en not_active Ceased
-
2002
- 2002-03-27 AR ARP020101141A patent/AR035451A1/es not_active Application Discontinuation
- 2002-04-02 HU HU0400317A patent/HUP0400317A3/hu unknown
- 2002-04-02 BR BRPI0208566-6B1A patent/BR0208566B1/pt not_active IP Right Cessation
- 2002-04-02 ES ES02745204T patent/ES2368389T3/es not_active Expired - Lifetime
- 2002-04-02 WO PCT/EP2002/003624 patent/WO2002081471A1/en not_active Ceased
- 2002-04-02 IL IL15754502A patent/IL157545A0/xx unknown
- 2002-04-02 PE PE2002000264A patent/PE20021018A1/es not_active Application Discontinuation
- 2002-04-02 CZ CZ20032655A patent/CZ295992B6/cs not_active IP Right Cessation
- 2002-04-02 AU AU2002316828A patent/AU2002316828B2/en not_active Ceased
- 2002-04-02 KR KR1020037012933A patent/KR100564840B1/ko not_active Expired - Fee Related
- 2002-04-02 EP EP02745204A patent/EP1377578B1/en not_active Expired - Lifetime
- 2002-04-02 PL PL362571A patent/PL210861B1/pl not_active IP Right Cessation
- 2002-04-02 JP JP2002579459A patent/JP4405732B2/ja not_active Expired - Fee Related
- 2002-04-02 NZ NZ528370A patent/NZ528370A/en not_active IP Right Cessation
- 2002-04-02 CN CNB028077814A patent/CN1309721C/zh not_active Expired - Fee Related
- 2002-04-02 RU RU2003130644/04A patent/RU2003130644A/ru not_active Application Discontinuation
- 2002-04-02 MY MYPI20021189A patent/MY134026A/en unknown
- 2002-04-02 SK SK1222-2003A patent/SK12222003A3/sk not_active Application Discontinuation
- 2002-04-02 US US10/472,630 patent/US6861430B2/en not_active Expired - Fee Related
- 2002-04-02 MX MXPA03009057A patent/MXPA03009057A/es active IP Right Grant
- 2002-04-02 AT AT02745204T patent/ATE517104T1/de active
- 2002-04-02 PT PT02745204T patent/PT1377578E/pt unknown
- 2002-04-02 CA CA2440014A patent/CA2440014C/en not_active Expired - Fee Related
-
2003
- 2003-08-07 ZA ZA200306108A patent/ZA200306108B/en unknown
- 2003-08-27 EC EC2003004754A patent/ECSP034754A/es unknown
- 2003-10-02 NO NO20034413A patent/NO20034413L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0108876D0 (en) | Organic Compounds | |
| GB0103389D0 (en) | Organic compounds | |
| GB0108606D0 (en) | Organic compounds | |
| GB0108337D0 (en) | Organic compounds | |
| GB0103303D0 (en) | Organic compounds | |
| GB0108087D0 (en) | Organic compounds | |
| GB0107368D0 (en) | Organic compounds | |
| GB0103258D0 (en) | Organic compounds | |
| GB0101598D0 (en) | Organic compounds | |
| GB0102841D0 (en) | Organic compounds | |
| GB0107365D0 (en) | Organic compounds | |
| GB0104438D0 (en) | Organic compounds | |
| GB0102089D0 (en) | Organic Compounds | |
| GB0102380D0 (en) | Organic compounds | |
| GB0102839D0 (en) | Organic compounds | |
| GB0102269D0 (en) | Organic compounds | |
| GB0102948D0 (en) | Organic compounds | |
| GB0103047D0 (en) | Organic Compounds | |
| GB0102093D0 (en) | Organic Compounds | |
| GB0102092D0 (en) | Organic compounds | |
| GB0108095D0 (en) | Organic compounds | |
| GB0104070D0 (en) | Organic compounds | |
| GB0104072D0 (en) | Organic compounds | |
| GB0104073D0 (en) | Organic compounds | |
| GB0108100D0 (en) | Organic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |